James S Duncan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Metastatic Breast Cancer

Radiofrequency Ablation

Top Venues

Science signaling

bioRxiv : the preprint server for biology

Fox Chase Cancer Center

Western University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fox Chase Cancer Center Jul 01 2013

United States

Assistant Professor :: Cancer Biology

Education History

Western University Sep 01 2003 - Aug 31 2008

Canada

PHD :: Biochemistry

Publications

Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase. bioRxiv : the preprint server for biology (2023)
Alison N Kurimchak, Carlos Herrera-Montávez, Sara Montserrat-Sangrà, Daniela Araiza-Olivera, Jianping Hu, Ryan Neumann-Domer, Mathew Kuruvilla, Alfonso Bellacosa, Joseph R Testa, Jian Jin, James S Duncan
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. Science signaling 15 (749) (2022)
Alison N Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, Katherine J Johnson, Valerie Sodi, Nishi Srivastava, Vikas Kumar, Safoora Deihimi, Shane O'Brien, Suraj Peri, Gina M Mantia-Smaldone, Angela Jain, Ryan M Winters, Kathy Q Cai, Jonathan Chernoff, Denise C Connolly, James S Duncan
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma. Science signaling 13 (619) (2020)